Martha Grogan
- Molecular Biology top 1%
- Cardiology and Cardiovascular Medicine top 0.5%
- Nephrology top 0.1%
- Oncology top 1%
- Rheumatology top 0.5%
- Co-authors
- Angela DispenzieriMorie A. GertzMathew S. MaurerFrederick L. RubergMazen HannaRobert A. KyleJeffery W. KellyKyle W. Klarich
- Topics
- Amyloidosis: Diagnosis, Treatment, Outcomes (144 papers)Parathyroid Disorders and Treatments (72 papers)Peptidase Inhibition and Analysis (27 papers)
- Journals
- CirculationSHILAP Revista de lepidopterologíaBlood
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Martha Grogan
170 papers receiving 7.9k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Molecular Biology 6.0k
- Cardiology and Cardiovascular Medicine 2.8k
- Nephrology 2.6k
- Oncology 1.8k
- Rheumatology 1.2k
Countries citing papers authored by Martha Grogan
This map shows the geographic impact of Martha Grogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha Grogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha Grogan more than expected).
Fields of papers citing papers by Martha Grogan
This network shows the impact of papers produced by Martha Grogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha Grogan. The network helps show where Martha Grogan may publish in the future.
Co-authorship network of co-authors of Martha Grogan
This figure shows the co-authorship network connecting the top 25 collaborators of Martha Grogan. A scholar is included among the top collaborators of Martha Grogan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martha Grogan. Martha Grogan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 2 | |
| 8 | 14 | |
| 9 | 4 | |
| 10 | 18 | |
| 11 | 18 | |
| 12 | 12 | |
| 13 | 76 | |
| 14 | Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosisbreakdown → | 316 |
| 15 | 22 | |
| 16 | Abstract 14214: ATTRibute-CM: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Global Phase 3 Study of AG10 in Patients With Transthyretin Amyloid Cardiomyopathy (ATTR-CM) | 5 |
| 17 | 180 | |
| 18 | 34 | |
| 19 | 185 | |
| 20 | 57 |
About Martha Grogan
Martha Grogan is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Molecular Biology, having authored 187 papers that have together received 8.1k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (144 papers), Parathyroid Disorders and Treatments (72 papers) and Peptidase Inhibition and Analysis (27 papers). The work is most often cited by research in Nephrology (2.6k citations), Cardiology and Cardiovascular Medicine (2.8k citations) and Molecular Biology (6.0k citations). Martha Grogan has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Angela Dispenzieri, Morie A. Gertz, Mathew S. Maurer, Frederick L. Ruberg, Mazen Hanna, Robert A. Kyle, Jeffery W. Kelly, Kyle W. Klarich, Bernard J. Gersh and Hugh C. Smith. Their work appears in journals such as Circulation, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.